1998
DOI: 10.1016/s0901-5027(05)80619-8
|View full text |Cite
|
Sign up to set email alerts
|

Myositis ossificans progressiva: five generations where the disease was exclusively limited to the maxillofacial region

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
13
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 22 publications
1
13
0
Order By: Relevance
“…Permanent restriction of the mouth opening due to the maxillofacial involvement is seen in 55% of the cases and occurs around the average age of 17.5 years [8].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Permanent restriction of the mouth opening due to the maxillofacial involvement is seen in 55% of the cases and occurs around the average age of 17.5 years [8].…”
Section: Discussionmentioning
confidence: 99%
“…Numerous medical regimens have been prescribed including calcitonin, nonsteroidal anti-inflammatory drugs and antimitotic agents but their efficacy has not been proven [8].…”
Section: Discussionmentioning
confidence: 99%
“…Death may result from complications by restrictive disease of the chest wall due to ankylosis of the spine and rib cage (Kussmail et al , 1998; Shore et al , 2000). Maxillofacial involvement leading to permanent restriction of mandibular opening is seen in approximately 80% of the cases and occurs on an average age of 18 years (Kabala et al , 1989; Debeney‐Bruyerre et al , 1998; Aslan et al , 1999; Chichareon et al , 1999; Herford and Boyne, 2003). Disease flare‐ups can occur spontaneously or can be induced by minor trauma, iatrogenic or not, as seen in the present case.…”
Section: Discussionmentioning
confidence: 99%
“…[6,10] There are less than 10 multi-generational families worldwide [3,4] and cases have been reported with exclusive compromise of the maxillofacial region. [22] It has an autosomal dominant pattern in 10% of the cases, but most patients (90%) correspond to a spontaneous "de novo" mutation in the gene that codes for the Activin A type I receptor like Activin-Kinase-2 (ACVR1 / ALK2) located on chromosome 2 (2q23-24). The ACVR1 / ALK2 receptor belongs to the family of bone morphogenetic protein (BMP) receptors, members of the superfamily of transforming growth factors beta (TGF-β).…”
Section: Introductionmentioning
confidence: 99%